Charlie Harper
Contact information
Research groups
Colleges
Charlie Harper
BSc, MSc, DPhil
Trial Data Scientist
Charlie is a data scientist working in the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) at Oxford Population Health.
His work aims to develop new trial methods to streamline large-scale randomised trials that produce reliable answers, including the use of healthcare systems data to recruit and follow-up participants. He lectures on the University of Oxford's MSc in Clinical Trials and MSc in Global Health Science and Epidemiology.
Charlie completed his undergraduate degree in Economics at the University of East Anglia and MSc in Economics at Bristol University. He obtained his DPhil in Population Health from Oxford Population Health, where he showed that UK healthcare systems data can be used to reliably follow-up participants in large cardiovascular trials.
Recent publications
-
Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospitalised with COVID-19 in England.
Journal article
Pessoa-Amorim G. et al, (2024), Trials, 25
-
Association of daily steps with incident non-alcoholic fatty liver disease: Evidence from the UK Biobank cohort
Preprint
Fulda ES. et al, (2024)
-
Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.
Journal article
Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk None. and Cholesterol Treatment Trialists’ (CTT) Collaboration None., (2024), The lancet. Diabetes & endocrinology, 12, 306 - 319
-
Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials.
Journal article
Sydes MR. et al, (2024), Contemporary clinical trials
-
Daily steps are a predictor of, but perhaps not a modifiable risk factor for Parkinson’s Disease: findings from the UK Biobank
Preprint
Acquah A. et al, (2024)